Trial record 48 of 195 for:
Oral Cancer | ( Map: Mexico )
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02711553 |
|
Recruitment Status :
Active, not recruiting
First Posted : March 17, 2016
Last Update Posted : March 5, 2019
|
Sponsor:
Eli Lilly and Company
Information provided by (Responsible Party):
Eli Lilly and Company
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | February 16, 2018 |
| Estimated Study Completion Date : | December 15, 2019 |
| Certification/Extension First Submitted : | February 8, 2019 |